Generic versus branded antiepileptic drug monotherapy for epilepsy

To assess the relative efficacy, safety and pharmacokinetic profiles of different generic AEDs relative to the respective branded drug for the treatment of epileptic seizures and to describe the hidden costs of generic versus branded AEDs narratively.

This is a protocol.